CA-XSOLLA
5.3.2024 14:01:29 CET | Business Wire | Press release
Xsolla, a global video game commerce company, has introduced Cross-Play and Cross-Pay, an innovative approach to mobile game monetization. In response to the evolving landscape, Xsolla’s suite of solutions enables mobile game developers to seamlessly transition their games from mobile to the web, desktop, and cloud while offering diverse monetization models out-of-the-box to power profitable direct-to-consumer sales for game developers.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240305100421/en/
(Graphic: Xsolla)
As the video game industry evolves, players anticipate engaging with their favorite titles seamlessly across all platforms, form factors, and control methods. This growing expectation places Cross-Play at the forefront of modern game development strategies. Mobile game developers can now effortlessly deploy their games across Mobile, PC, Console, Cloud, and Web with Xsolla Launcher and Xsolla Cloud Gaming.
Xsolla Launcher makes it easier for developers to leverage the capabilities of desktop computing, including enhanced graphics, gameplay depth, and longer play sessions when porting mobile games to PC.
Cloud Gaming for Mobile Games, in turn, is a strategic extension of the core Xsolla Cloud Gaming solution. It enables mobile video game developers to expand cross-platform by deploying game builds to cloud platforms directly from the developer's own branded landing page, allowing them to deliver flexible monetization mechanics for mobile users.
Cross-Play experience ensures consistent and fair monetization strategy across all platforms for developers around the world. This approach ensures equal access to game content for players, thereby enhancing the overall playing experience while adhering to platform rules and guidelines. Xsolla Web Shop, a leading solution for web purchases, is a foundation for the Direct-to-Consumer strategy for mobile game developers.
Web Shops are easily customizable branded online stores fully equipped to facilitate in-game web purchases. The next iteration of the Xsolla Web Shop Solution includes innovative updates drawing on Xsolla's expertise gained from launching over 210 Web Shops and 40 of the top 100 highest-grossing mobile games worldwide. Xsolla Web Shop introduces advanced LiveOps tools, additional personalization and engagement features, and an improved user flow for seamless purchases. Alongside these enhancements, Xsolla's experts are always available to offer guidance and support by providing best practices consultation in navigating the operation and management of web shops.
“The advancements made with Cross-Play Cross-Pay have been a focus of our innovation over the past year after collaborating with numerous partners and launching over 200 web shops in 2023. This extensive real-world application with customer feedback has helped mobile game developers to efficiently market their games online by operating within the platform guidelines,” said David Stelzer, President of Xsolla. “Cross-Play Cross-Pay is our strategic innovation to meet the continuously evolving demands of the ever-changing mobile game industry. By delivering a multi-platform solution for mobile game developers, we can help them to reach more players and to grow their business.”
This comprehensive suite of Cross-Play Cross-Pay solutions empowers mobile developers to ensure their games reach the widest possible audience by establishing deep and lasting connections with players around the globe.
For more information about Xsolla Web Shop 2.0 and its features, please visit: xsolla.pro/web-shop2
For more information about Xsolla Cloud Gaming for mobile and its features, please visit: xsolla.pro/cloud-gaming
For more information about Xsolla Launcher, please visit: xsolla.pro/xsolla-launcher
About Xsolla
Xsolla is a global video game commerce company with a robust and powerful set of tools and services designed specifically for the industry. Since its founding in 2005, Xsolla has helped thousands of game developers and publishers of all sizes fund, market, launch and monetize their games globally and across multiple platforms. As an innovative leader in game commerce, Xsolla’s mission is to solve the inherent complexities of global distribution, marketing, and monetization to help our partners reach more geographies, generate more revenue, and create relationships with gamers worldwide. Headquartered and incorporated in Los Angeles, California, with offices in London, Berlin, Seoul, Beijing, Kuala Lumpur, Raleigh, Tokyo, and cities around the world, Xsolla supports major gaming titles like Valve, Twitch, Roblox, Epic Games, Take-Two, KRAFTON, Nexters, NetEase, Playstudios, Playrix, miHoYo, and more.
For additional information and to learn more, please visit: xsolla.com
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240305100421/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Incyte Announces Positive CHMP Opinion for Zynyz® (retifanlimab) for First-Line Treatment of Advanced Squamous Cell Carcinoma of the Anal Canal (SCAC)30.1.2026 15:29:00 CET | Press release
Pending the European Commission decision, Zynyz® (retifanlimab) in combination with carboplatin and paclitaxel (platinum-based chemotherapy) will be the first PD-1 immunotherapy treatment for patients with advanced squamous cell carcinoma of the anal canal (SCAC) in EuropeGlobally, the prevalence of SCAC is estimated at around 1 or 2 cases per 100,000 people, with a higher incidence in women than in men1,2,3The Committee for Medicinal Products for Human Use (CHMP) positive opinion is based on data from the Phase 3 POD1UM-303/InterAACT2 trial which showed patients with advanced SCAC achieved significantly improved progression-free survival with Zynyz in combination with carboplatin and paclitaxel as a first-line treatment4 Incyte (Nasdaq:INCY) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion recommending the approval of Zynyz® (retifanlimab) in combination with carboplatin and paclitaxel (
Mediawan to Acquire The North Road Company, Creating a New Global Independent Content Platform30.1.2026 13:32:00 CET | Press release
Mediawan, the leading independent European studio led by Pierre-Antoine Capton, co-founded by Capton, Xavier Niel and Matthieu Pigasse, today announced the signing of an agreement to acquire The North Road Company (“North Road”), the preeminent independent U.S.-based studio founded by Peter Chernin. The combination creates one of the world’s largest independent studios with major creative hubs in the five continents and capabilities spanning all genres, formats and audiences. Together, Mediawan and North Road will have a stronger ability to accelerate the development of powerful IP, foster fresh creative synergies through format adaptations and co-production opportunities, and deliver ever greater value to viewers, talent and partners worldwide. The acquisition brings together two of the most dynamic independent studios in the sector with world-class creative talent, premium IP, and the scale to deliver content at the highest level. In an industry undergoing significant consolidation,
BrightSign Powers Intelligent Signage Experiences at ISE 202630.1.2026 09:00:00 CET | Press release
The Latest Players and AI Capabilities Drive Captivating, Personalized, and Interactive Signage With more industries embracing the power of visual storytelling, BrightSign, the provider of the most advanced, capable, and trusted digital media players and operating system, will showcase the latest developments in digital signage technology at ISE 2026 in Barcelona, Spain from February 3-6, 2026. BrightSign’s latest innovations come to life at booth #4S-150 through interactive real-world demos featuring retail, QSR, transportation, and corporate use cases. Visitors can test new AI-powered object detection capabilities of BrightSign players, allowing them to pick up an object and see the content on the screen respond immediately. Booth activations will be powered by BrightSign’s reliable platform including bsn.Control, BrightSignOS™, brightAuthor connected, and its global partner ecosystem. “In today’s immersive, personalized and visual world, the stakes have never been higher for powerfu
Candela Ushers in a New Era of Aesthetic Innovation at IMCAS Paris With the Launch of the Glacē™ System30.1.2026 08:30:00 CET | Press release
Iconic Vbeam® Pro and Matrix™ Systems showcased ahead of broader commercial availability Candela, a global leader in energy-based aesthetic technologies, today announced the European launch of the Glacē™ System, a facial treatment platform that signals a bold new chapter for the company and the future of aesthetic medicine. In addition to the launch of the Glacē System, Candela will also showcase its Matrix system for radiofrequency-based skin renewal and its iconic Vbeam® Pro vascular treatment platform at IMCAS 2026. Both Matrix and VBeam Pro platforms are currently available in select EMEA markets and are expected to be comprehensively launched shortly, further strengthening Candela’s leadership in the energy-based device market. Unveiled at the IMCAS World Congress 2026, these launches underscore Candela’s continued commitment to delivering innovative, science-backed treatment solutions for high-demand patient needs. Candela leads the industry in clinical efficacy and safety, suppo
Merz Therapeutics Appoints Dan Staner as President, Region Europe30.1.2026 08:00:00 CET | Press release
Merz Therapeutics today announced the appointment of Dan Staner as President, Region Europe, effective February 1, 2026. In this role, Dan will oversee the company’s European business and drive regional growth. Dan will report directly to Merz Therapeutics Chief Executive Officer, Stefan König, and will join the Therapeutics Executive Team. His appointment reflects the company’s continued commitment to strengthening its leadership capabilities and accelerating its growth strategy across key European markets. “Dan brings a strong track record of building and scaling biopharmaceutical businesses across Europe,” said Stefan König, CEO of Merz Therapeutics. “His deep commercial, strategic, and regional leadership experience will be instrumental in advancing our growth ambitions, expanding patient access to our therapies, and further strengthening our presence in Europe. We are very pleased to welcome Dan to Merz Therapeutics.” Throughout his career, Dan has held senior leadership roles i
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
